|
|
|
|
| LEADER |
01600nam a22003615i 4500 |
| 001 |
000277771 |
| 005 |
20210625134415.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140227s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493902613
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-0261-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Clinical Applications of Botulinum Neurotoxin /
|c edited by Keith A. Foster.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XI, 196 p. 12 illus., 8 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Neurotoxicity,
|v 5
|
| 505 |
0 |
|
|a Botulinum Toxin as a Clinical Product -- Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders -- Clinical Use of Botulinum Neurotoxin: Autonomic Conditions -- Clinical Use of Botulinum Neurotoxin: Urogenital Disorders Including Overactive Bladder -- Clinical Use of Botulinum Neurotoxins: Pain -- Future Developments: Engineering the Neurotoxin. .
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
1 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Biomedicine, general.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Foster, Keith A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|